Gelatin Sponge Closure Device versus Manual Compression after Peripheral Arterial Catheterization Procedures

Journal of Vascular and Interventional Radiology

Volumn 14, Issue 12, 2003, Pages 1517-1523

  Castañeda, Flavio ^a   Swischuk, James L ^a   Smouse, H Bob ^a   Brady, Terry ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN RECEPTOR ANTAGONIST; GELATIN SPONGE; GELFOAM;

ADULT; AGED; ARTERIOTOMY; ARTERY CATHETERIZATION; ARTICLE; BIOCOMPATIBILITY; CLINICAL TRIAL; COMPRESSION THERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEVICE; FEMALE; FEMORAL ARTERY; HEART CATHETERIZATION; HEMATOMA; HEMOSTASIS; HUMAN; INTERMETHOD COMPARISON; INTERVENTIONAL RADIOLOGY; MAJOR CLINICAL STUDY; MALE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 0345167836     PISSN: 10510443     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.RVI.0000099530.29957.DD     Document Type: Article

References (26)

1. Coto HA. Closure of the femoral vein puncture site after transcatheter procedures using angio-seal. Cathet Cardiovasc Intervent 2002: 5516-5519.
2. Khosla S, Kunjummen B, Guerrero M, Manda R, Razminia M, Ahmed A. Suture-mediated closure of the femoral access site after cardiac catheterization: results of the Suture To Ambulate and Discharge (STAND 1 and STAND 11) trials. Am J Cardiol 2000; 85:864-869.
3. Sanborn TA, Gibbs HH, Brinker JA, Knopf WD, Kosinski EJ, Roubin GS. A multicenter randomized trial comparing a percutaneous collagen hemostasis device with manual compression after diagnostic angiography and angioplasty. J Am Coll Cardiol 1993; 22: 1273-1279.
4. Brachmann J, Ansah M, Kosinski EJ, Schuler GC. Improved clinical effectiveness with a collagen vascular hemostasis device for shortened immobilization time following diagnostic angiography and percutaneous transluminal coronary angioplasty. Am J Cardiol 1998; 81:1501-1505.
5. Ernst SM, Tjonjoegin RM, Schrader R, et al. Immediate sealing of arterial puncture sites after cardiac catheterization and coronary angioplasty using a biodegradable collagen plug: results of an international registry. J Am Coll Cardiol 1993; 21:851-855.
6. Aker UT, Kensey KR, Heuser RR, Sandza JG, Kussmaul WG III. Immediate arterial hemostasis after cardiac catheterization - initial experience with a new puncture closure device. Cathet Cardiovasc Diagn 1994; 31:229-232.
7. Kussmaul WG III, Buchbinder M, Whitlow PL, et al. Rapid arterial hemostasis after cardiac catheterization and percutaneous transluminal angioplasty-results of a randomized trial of a novel homeostatic device. J Am Coll Cardiol 1995; 25:1685-1692.
8. Henry M, Amor M, Allaoui M, Tricoche O. A new access site management tool: the Angio-Seal hemostatic puncture closure device. J Endovasc Surg 1995; 1:290-296.
9. Gershony G, Brock JM, Powell JS. Novel vascular sealing device for closure of percutaneous vascular access sites. Cathet Cardiovasc Diagn 1998; 45:82-88.
10. Carere RG, Webb JG, Ahmed T, Dodek AA. Initial experience with Prostar, a new device for percutaneous suture-mediated closure of the arterial puncture site. Cathet Cardiovasc Diagn 1996; 37:367-372.
11. Crocker CH, Cragun KT, Timimi FK, et al. Immediate ambulation following diagnostic coronary angiography procedures utilizing a vascular closure device (the Closer). J Invasive Cardiol 2002; 14:728-732.
12. Stiel GM, Beythien C, Kalkowski H, et al. Peripheral embolism of hemostasis collagen (Vasoseal). Z Kardiol 1992; 81:543-545.
13. Carey D, Martin JR, Moore CA, Valentine MC, Nygaard TW. Complications of femoral artery closure devices. Cathet Cardiovasc Intervent 2001; 52: 3-7.
14. Cura FA, Kapadia SR, L'Allier PL, et al. Safety of femoral closure devices after percutaneous coronary interventions in the era of glycoprotein IIb/IIa platelet blockade. Am J Cardiol 2000; 86: 780-782
15. Smith TP, Cruz CP, Moursi MM, Eidt JF. Infectious complications resulting from use of hemostatic puncture closure devices. Am J Surg 2001; 182:658-662.
16. Seiler RW, Mariani L. Sellar reconstruction with resorbable Vicryl patches, gelatin foam, and fibrin glue in transsphenoidal surgery: a 10 year experience with 376 patients. J Neurosurg 2000; 93:762-765.
17. Weaver FA, Hood DB, Zatina M, Messina L, Badduke B. Gelatin-thrombin-based hemostatic sealant for intraoperative bleeding in vascular surgery. Ann Vasc Surg 2002; 16:286-293.
18. Shrake KL. Comparison of major complication rates associated with four methods of arterial closure. Am J Cardiol 2000; 85:1024-1025.
19. Khoury M, Batra S, Berg R, Rama K, Kozul V. Influence of arterial sites and interventional procedures on vascular complications after cardiac catheterization. Am J Surg 1992; 164:205-210.
20. Muller DW, Shamir KJ, Ellis SG, Topol EJ. Peripheral vascular complications after conventional and complex percutaneous coronary interventional procedures. Am J Cardiol 1992; 60:62-68.
21. Ricci MA, Trevisani GT, Pilcher DB. Vascular complications of cardiac catheterization. Am J Surg 1994; 167:375-378.
22. Duffin DC, Muhlestein JB, Allisson SB, et al. Femoral arterial puncture management after percutaneous coronary procedures: a comparison of clinical outcomes and patient satisfaction between manual compression and two different vascular closure devices. J Invas Cardiol 2002; 13:354-362.
23. Johanning JM, Franklin DP, Elmore JR, Han DC. Femoral artery infections associated with percutaneous arterial closure devices. J Vasc Surg 2001; 34: 983-985.
24. Beyer-Enke SA, Soldner J, Zeitler E. Immediate sealing of arterial puncture site following femoropopliteal angioplasty: a prospective randomized trial. Cardiovasc Intervent Radiol 1996; 19406-19410.
25. Duda SH, Wiskirchen J, Erb M, et al. Suture-mediated percutaneous closure of antegrade femoral arterial access sites in patients who have received full anticoagulation therapy. Radiology 1999; 210:47-52.
26. Balzer JO, Scheinert D, Diebold T, Haufe M, Vogl TJ, Biamino G. Postinterventional transcutaneous suture of femoral artery access sites in patients with peripheral arterial occlusive disease: a study of 930 patients. Cathet Cardiovasc Intervent 2001; 53:174-181.